ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories
July 06, 2021Everest Medicines announced that Spero Therapeutics, Inc., entered into a regional licensing agreement with Pfizer Inc. for SPR206. -
Spero Receives Orphan Drug Designation for Nontuberculous Mycobacterial Treatment
March 12, 2020Spero Therapeutics announced the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for oral SPR720 for the treatment of nontuberculous mycobacterial (NTM) infection. -
Spero Reports Preliminary Findings from SPR720 Trial
December 10, 2019Spero Therapeutics announced preliminary findings from a Phase 1 first-in-human clinical trial of SPR720, its oral antimicrobial agent in development for the treatment of ...
Pharma Sources Insight January 2025
